Newtyn Management

Newtyn Management follows a multi-strategy approach centered on event-driven investing, special situations, and fundamental long-short equity. It invests across public and private markets, with a strong focus on healthcare where Sauer has deep expertise. The firm also engages in merger arbitrage and distressed investing.

Newtyn Management has held significant positions in healthcare companies such as Mallinckrodt, The Medicines Company, and Brookdale Senior Living (per public filings). The firm is known for taking concentrated positions in specialty pharmaceuticals and healthcare services. It often invests in situations where it sees dislocations or operational catalysts.

Yes, Newtyn Management sometimes takes activist or collaborative positions, particularly in special situations and restructurings. The firm works with management teams to implement strategic changes or improve operational efficiency. Historically, it has used private engagement rather than public campaigns.

Newtyn Management's capital primarily comes from institutional investors, family offices, and high-net-worth individuals. The firm does not disclose its full investor list publicly. It is not affiliated with a single family or corporate entity.